Form 8K ONCOTELIC
THERAPEUTICS For: 6 January
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Oncotelic Therapeutics Inc (OTLC)
Assess today's live Oncotelic Therapeutics Inc (OTLC) share price, performance and insights using our live OTC Markets: OTLC stock exchange data.
Analyse the historical data and Oncotelic Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Oncotelic Therapeutics share price buy/sell indicators using real-time data (or discuss the Oncotelic Therapeutics (OTLC) stock price today with other investors in the Oncotelic Therapeutics OTC share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current OTC OTLC share price (ISIN: US6283411097) to enhance your trading decisions with our free investment tools and resources.
What Is the Oncotelic Therapeutics Inc Share Price Today?
The Oncotelic Therapeutics share price today is 0.0766.
What Is the Stock Symbol for Oncotelic Therapeutics Inc
The stock symbol (or 'ticker') for Oncotelic Therapeutics Inc is "OTLC."
What Stock Exchange Does Oncotelic Therapeutics Inc Trade On?
Oncotelic Therapeutics Inc is listed and trades on the OTC Markets stock exchange.
Is Oncotelic Therapeutics Inc a Good Stock to Buy?
Determining whether Oncotelic Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Oncotelic Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Oncotelic Therapeutics share price buy/sell indicators using real-time data (or discuss the Oncotelic Therapeutics (OTLC) stock price today with other investors in the Oncotelic Therapeutics OTC share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current OTC OTLC share price (ISIN: US6283411097) to enhance your trading decisions with our free investment tools and resources.
What Is the Oncotelic Therapeutics Inc Share Price Today?
The Oncotelic Therapeutics share price today is 0.0766.
What Is the Stock Symbol for Oncotelic Therapeutics Inc
The stock symbol (or 'ticker') for Oncotelic Therapeutics Inc is "OTLC."
What Stock Exchange Does Oncotelic Therapeutics Inc Trade On?
Oncotelic Therapeutics Inc is listed and trades on the OTC Markets stock exchange.
Is Oncotelic Therapeutics Inc a Good Stock to Buy?
Determining whether Oncotelic Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
OTC Markets
Currency in USD
0.0766
-0.0053(-6.47%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0728
0.0797
52 wk Range
0.0251
0.1100
OTLC is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.07280.0797
52 wk Range
0.02510.1100
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
OTLC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
- Form 8K ONCOTELIC THERAPEUTICS For: 9 December
- Investing.com
- Form 8K ONCOTELIC THERAPEUTICS For: 6 January
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Oncotelic Therapeutics Company Profile
Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment of orphan oncology indications. It develops antisense and small molecule injectable drugs for the treatment of cancer. The company is also developing OXi4503 for the treatment of acute myeloid leukemia and myelodysplastic syndromes; OT-101, an antisense against TGF-ß2, which is in phase 3 clinical trials for pancreatic cancer and glioblastoma, as well as for the treatment of various viruses, including severe acute respiratory syndrome and coronavirus. In addition, it develops CA4P for the treatment of advanced metastatic melanoma; AL-101, an intranasal drug and delivery system for intra-nasal apomorphine for the treatment of parkinson’s disease, erectile disfunction, and female sexual disfunction; Artemisinin, a natural derivative from an Asian herb Artemisia Annua; and AI based technologies to enhance the development and commercialization of support technologies, as well as nanoparticle products for the treatments of various cancers. The company is based in Agoura Hills, California.
Compare OTLC to Peers and Sector
Metrics to compare | OTLC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipOTLCPeersSector | |
|---|---|---|---|---|
P/E Ratio | −25.4x | −3.9x | −0.6x | |
PEG Ratio | −0.38 | 0.10 | 0.00 | |
Price/Book | 4.7x | 4.0x | 2.6x | |
Price / LTM Sales | - | 9.6x | 3.4x | |
Upside (Analyst Target) | - | 74.7% | 42.5% | |
Fair Value Upside | Unlock | −13.4% | 5.8% | Unlock |
Earnings
Latest Release
Nov 28, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
FAQ
What Is the Oncotelic Therapeutics (OTLC) Share Price Today?
The live Oncotelic Therapeutics share price today is 0.0766
What Stock Exchange Does Oncotelic Therapeutics (OTLC) Trade On?
Oncotelic Therapeutics is listed and trades on the OTC Markets.
What Is the Ticker (Stock Symbol) for Oncotelic Therapeutics?
The stock symbol (also called a 'ticker') for Oncotelic Therapeutics is "OTLC."
What Is the Current Oncotelic Therapeutics Market Cap?
As of today, Oncotelic Therapeutics market capitalisation is 39.62M.
What Is Oncotelic Therapeutics's (OTLC) Earnings Per Share (TTM)?
The Oncotelic Therapeutics EPS is currently -0.00 (Trailing Twelve Months).
When Is the Next Oncotelic Therapeutics Earnings Date?
Oncotelic Therapeutics's next earnings report will be released on 19 Apr 2026.
Is OTLC a Buy or Sell From a Technical Analyst Perspective?
Based on today's Oncotelic Therapeutics moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Oncotelic Therapeutics Stock Split?
Oncotelic Therapeutics has split 2 times. (See the OTLC stock split history page for full effective split date and price information.)
How Many Employees Does Oncotelic Therapeutics Have?
Oncotelic Therapeutics has 26 employees.
What is the current trading status of Oncotelic Therapeutics (OTLC)?
As of 22 Jan 2026, Oncotelic Therapeutics (OTLC) is trading at a price of 0.0766, with a previous close of 0.0819. The stock has fluctuated within a day range of 0.0728 to 0.0797, while its 52-week range spans from 0.0251 to 0.1100.
What Is the OTLC After Hours Price?
OTLC's last after hours stock price is 0.0500, the stock has decreased by -0.0010, or -1.9600%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.